A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

Disruption of histone acetylation patterns is a common feature of cancer cells, but very little is known about its genetic basis. We have identified truncating mutations in one of the primary human histone deacetylases, HDAC2, in sporadic carcinomas with microsatellite instability and in tumors aris...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature genetics 2006-05, Vol.38 (5), p.566-569
Hauptverfasser:	Esteller, Manel, Ropero, Santiago, Fraga, Mario F, Ballestar, Esteban, Hamelin, Richard, Yamamoto, Hiroyuki, Boix-Chornet, Manuel, Caballero, Rosalia, Alaminos, Miguel, Setien, Fernando, Paz, Maria F, Herranz, Michel, Palacios, Jose, Arango, Diego, Orntoft, Torben F, Aaltonen, Lauri A, Schwartz, Simó
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino Acid Sequence Antineoplastic Agents - therapeutic use Apoptosis Biological and medical sciences Cancer Cell Cycle Colorectal carcinoma Drug Resistance, Neoplasm - genetics Electrophoresis, Capillary Enzymatic activity Enzyme Inhibitors - pharmacology Fundamental and applied biological sciences. Psychology Gene expression Genetics of eukaryotes. Biological and molecular evolution Histone Deacetylase 2 Histone Deacetylase Inhibitors Histone Deacetylases - chemistry Histone Deacetylases - genetics Humans Inhibitor drugs Molecular Sequence Data Mutation Neoplasms - drug therapy Neoplasms - enzymology Neoplasms - genetics Neoplasms - pathology Repressor Proteins - antagonists & inhibitors Repressor Proteins - chemistry Repressor Proteins - genetics RNA, Small Interfering
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!